 NEW YORK, Sept. 02, 2021 GLOBE NEWSWIRE -- Delcath Systems, Inc. Nasdaq: DCTH, an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced today it will participate in three upcoming conferences: 